Nettis E - Search Results

1

Omalizumab in chronic spontaneous urticaria: Efficacy, safety, predictors of treatment outcome, and time to response.

Nettis E, Cegolon L, Di Leo E, Lodi Rizzini F, Detoraki A, Canonica GW; Italian OCUReL study group. Nettis E, et al. Ann Allergy Asthma Immunol. 2018 Oct;121(4):474-478. doi: 10.1016/j.anai.2018.06.014. Epub 2018 Jun 24. Ann Allergy Asthma Immunol. 2018. PMID: 29949781 Free article.

2

Tolerability of rofecoxib in patients with cutaneous adverse reactions to nonsteroidal anti-inflammatory drugs.

Nettis E, Di PR, Ferrannini A, Tursi A. Nettis E, et al. Ann Allergy Asthma Immunol. 2002 Mar;88(3):331-4. doi: 10.1016/s1081-1206(10)62017-0. Ann Allergy Asthma Immunol. 2002. PMID: 11926629

3

Short-term and long-term tolerability of rofecoxib in patients with prior reactions to nonsteroidal anti-inflammatory drugs.

Nettis E, Colanardi MC, Ferrannini A, Tursi A. Nettis E, et al. Ann Allergy Asthma Immunol. 2005 Jan;94(1):29-33. doi: 10.1016/S1081-1206(10)61281-1. Ann Allergy Asthma Immunol. 2005. PMID: 15702812

4

Short-term tolerability of etoricoxib in patients with cutaneous hypersensitivity reactions to nonsteroidal anti-inflammatory drugs.

Nettis E, Colanardi MC, Ferrannini A, Vacca A, Tursi A. Nettis E, et al. Ann Allergy Asthma Immunol. 2005 Nov;95(5):438-42. doi: 10.1016/S1081-1206(10)61169-6. Ann Allergy Asthma Immunol. 2005. PMID: 16312166 Clinical Trial.

5

Safety of parecoxib in patients with nonsteroidal anti-inflammatory drug-induced urticaria or angioedema.

Colanardi MC, Nettis E, Traetta P, Daprile C, Fitto C, Aloia AM, Di Leo E, Ferrannini A, Vacca A. Colanardi MC, et al. Among authors: nettis e. Ann Allergy Asthma Immunol. 2008 Jan;100(1):82-5. doi: 10.1016/S1081-1206(10)60409-7. Ann Allergy Asthma Immunol. 2008. PMID: 18254487 Clinical Trial.

6

The safety of a novel sublingual rush induction phase for latex desensitization.

Nettis E, Di Leo E, Calogiuri G, Milani M, Delle Donne P, Ferrannini A, Vacca A. Nettis E, et al. Curr Med Res Opin. 2010 Aug;26(8):1855-9. doi: 10.1185/03007995.2010.490671. Curr Med Res Opin. 2010. PMID: 20521869 Clinical Trial.

7

Adherence issues related to sublingual immunotherapy as perceived by allergists.

Scurati S, Frati F, Passalacqua G, Puccinelli P, Hilaire C, Incorvaia C; Italian Study Group on SLIT Compliance. Scurati S, et al. Patient Prefer Adherence. 2010 Jun 24;4:141-5. doi: 10.2147/ppa.s10217. Patient Prefer Adherence. 2010. PMID: 20622914 Free PMC article.

8

Hypersensitivity to tranexamic acid: a wide spectrum of adverse reactions.

Imbesi S, Nettis E, Minciullo PL, Di Leo E, Saija A, Vacca A, Gangemi S. Imbesi S, et al. Among authors: nettis e. Pharm World Sci. 2010 Aug;32(4):416-9. doi: 10.1007/s11096-010-9415-8. Epub 2010 Jul 15. Pharm World Sci. 2010. PMID: 20632108

9

The employment of leukotriene antagonists in cutaneous diseases belonging to allergological field.

Nettis E, D'Erasmo M, Di Leo E, Calogiuri G, Montinaro V, Ferrannini A, Vacca A. Nettis E, et al. Mediators Inflamm. 2010;2010:628171. doi: 10.1155/2010/628171. Epub 2010 Sep 22. Mediators Inflamm. 2010. PMID: 20886028 Free PMC article. Review.

10

Immediate-type hypersensitivity to systemic glucocorticoids: an underrated drug allergy.

Calogiuri G, Di Leo E, Nettis E, Vacca A, Ferrannini A. Calogiuri G, et al. Among authors: nettis e. J Allergy Clin Immunol. 2011 Jul;128(1):251; author reply 251-2. doi: 10.1016/j.jaci.2011.04.021. Epub 2011 May 11. J Allergy Clin Immunol. 2011. PMID: 21565390 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

214 results

Search Page

Filters